Patents by Inventor Cynthia Levinthal

Cynthia Levinthal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human metabotropic glutamate receptor
    Patent number: 7241863
    Abstract: A novel human metabotropic glutamate receptor (mGluR) protein is identified, sequenced, and cloned. The receptor may be used to screen for compounds that modulate the activity of the mGluR. The recombinant mGluR, as well as compounds that modulate mGluR activity, may be used in the diagnosis and treatment of neurological disorders and diseases.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: July 10, 2007
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Karen J. Krapcho, Thomas M. Stormann, Cynthia Levinthal, Lance G. Hammerland, Laura Storjohann
  • Novel human metabotropic glutamate receptor
    Publication number: 20030157647
    Abstract: A novel human metabotropic glutamate receptor (mGluR) protein is identified, sequenced, and cloned. The receptor may be used to screen for compounds that modulate the activity of the mGluR. The recombinant mGluR as well as compounds that modulate mGluR activity may be used in the diagnosis and treatment of neurological disorders and diseases.
    Type: Application
    Filed: January 17, 2003
    Publication date: August 21, 2003
    Inventors: Karen J. Krapcho, Thomas M. Stormann, Cynthia Levinthal, Lance G. Hammerland, Laura Storjohann
  • Human metabotropic glutamate receptor
    Patent number: 6534287
    Abstract: A novel human metabotropic glutamate receptor (mGluR) protein is identified, sequenced, and cloned. The receptor may be used to screen for compounds that modulate the activity of the mGluR. The recombinant mGluR as well as compounds that modulate mGluR activity may be used in the diagnosis and treatment of neurological disorders and diseases.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: March 18, 2003
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Karen J. Krapcho, Thomas M. Stormann, Cynthia Levinthal, Lance G. Hammerland